2 completed, 1 unknown. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Retroperitoneal Fibrosis: new trials by email Literature Review of Retroperitoneal Fibrosis trials Research Report on Retroperitoneal Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis Sirolimus, Corticosteroid - Retroperitoneal Fibrosis | Phase 2 / Phase 3 | Completed | Peking University International Hospital | 64 | 2018-07-01 | 2026-09-22 |
| Rituximab in IgG4-RD: A Phase 1-2 Trial Rituximab - Retroperitoneal Fibrosis, Autoimmune Pancreatitis | Phase 1 / Phase 2 | Completed | Massachusetts General Hospital | 30 | 2012-04-01 | 2017-07-02 |
| Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis Tamoxifen, Prednisone - Retroperitoneal Fibrosis | Phase 2 | Unknown | University of Parma | 38 | 2000-10-01 | 2007-02-27 |
Autoimmune Pancreatitis (1) · Lymphadenopathy (1) · Meningitis (1) · Orbital Pseudotumor (1) · Sialadenitis (1)
Fibrosis (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Autoimmune Diseases (1) · Chronic Disease (1) · Digestive System Diseases (1) · Disease Attributes (1) · Eye Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Lymphatic Diseases (1) · Mouth Diseases (1) · Nervous System Diseases (1) · Neuroinflammatory Diseases (1) · Orbital Diseases (1)
Prednisone (2) · Adrenal Cortex Hormones (1) · Rituximab (1) · Sirolimus (1) · Tamoxifen (1)
Massachusetts General Hospital (1) · Peking University International Hospital (1) · University of Parma (1)
China (1) · Italy (1)
Arezou Khosroshahi, MD (1) · Carlo Buzio, MD (1) · Hui Gao, Doctor (1) · John H Stone, MD, MPH (1)